SCHEMBL9707500

SCHEMBL9707500

CCn1c(=O)n(C(C)c2ccccc2)c(=O)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707599 0.94 ADORA3 (0.40) —
SCHEMBL9707836 0.94 ADORA3 (0.35) —
SCHEMBL9708553 0.93 PPARG (0.35) —
SCHEMBL9708566 0.92 AGTR1 (0.38) —
SCHEMBL9708607 0.91 DPP4 (0.38) —
SCHEMBL9708550 0.91 AGTR1 (0.41) —
SCHEMBL9708116 0.90 PDE5A (0.41) —
SCHEMBL9707891 0.90 AGTR1 (0.35) —
SCHEMBL9708014 0.90 AGTR1 (0.36) —
SCHEMBL9707685 0.90 PPARG (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 — — WO disclosed
Send feedback